Benchmarking in Medication Safety: A Report from the Alliance of Dedicated Cancer Centers Patient Safety Organization

Benchmarking is commonly used in health care to compare performance among providers. However, medication safety has largely been exempt from this type of benchmarking: using voluntarily reported medication safety events for cross-institutional performance comparisons is discouraged because these data are not directly comparable. The member hospitals of the Alliance of Dedicated Cancer Centers (ADCC) launched a Patient Safety Organization (PSO)-supported Medication Quality and Safety Dashboard project to examine whether this cohort was similar enough that benchmarking could illuminate medication safety vulnerabilities and best practices. In this retrospective analysis, the authors evaluated institutional demographics, pharmacy volume metrics, and deidentified medication safety event reports from existing systems; developed a severity crosswalk; standardized key event definitions; normalized event rates per 10,000 doses dispensed or administered; and calculated a near-miss event (NME) ratio as a marker of reporting culture. Despite these efforts, the study revealed that heterogeneity in reporting platforms, system configurations, data capture practices, and institutional size produced wide variability and significant outliers in event volumes and rates, precluding meaningful cross-institutional performance comparisons. The authors' findings reaffirm long-standing cautions against benchmarking voluntarily reported event data across institutions, even among seemingly similar cancer centers. However, they found practical value from internal use of the NME ratio to assess reporting culture and error interception, and from collaborative work to standardize taxonomy for medication safety events that goes beyond the medication-use phase and medication type. They identified best practices for using internal medication-related safety data. These lessons can be applied to the incorporation of AI as more tools and literature support become available.

Authors

Institutions

Publication Details

Journal
NEJM Catalyst
Published
2026-11-18
DOI
https://doi.org/10.1056/cat.26.0163
Primary Topic
Patient Safety and Medication Errors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Benchmarking in Medication Safety: A Report from the Alliance of Dedicated Cancer Centers Patient Safety Organization

Amber D. Hartman, Andrew P Stivers, Amelia Chan, Laura Boehnke Michaud et al.
NEJM Catalyst
Patient Safety and Medication Errors
article

Benchmarking in Medication Safety: A Report from the Alliance of Dedicated Cancer Centers Patient Safety Organization

Amber D. Hartman, Andrew P Stivers, Amelia Chan, Laura Boehnke Michaud, Daniel Kudryashov
article en

Abstract

Benchmarking is commonly used in health care to compare performance among providers. However, medication safety has largely been exempt from this type of benchmarking: using voluntarily reported medication safety events for cross-institutional performance comparisons is discouraged because these data are not directly comparable. The member hospitals of the Alliance of Dedicated Cancer Centers (ADCC) launched a Patient Safety Organization (PSO)-supported Medication Quality and Safety Dashboard project to examine whether this cohort was similar enough that benchmarking could illuminate medication safety vulnerabilities and best practices. In this retrospective analysis, the authors evaluated institutional demographics, pharmacy volume metrics, and deidentified medication safety event reports from existing systems; developed a severity crosswalk; standardized key event definitions; normalized event rates per 10,000 doses dispensed or administered; and calculated a near-miss event (NME) ratio as a marker of reporting culture. Despite these efforts, the study revealed that heterogeneity in reporting platforms, system configurations, data capture practices, and institutional size produced wide variability and significant outliers in event volumes and rates, precluding meaningful cross-institutional performance comparisons. The authors' findings reaffirm long-standing cautions against benchmarking voluntarily reported event data across institutions, even among seemingly similar cancer centers. However, they found practical value from internal use of the NME ratio to assess reporting culture and error interception, and from collaborative work to standardize taxonomy for medication safety events that goes beyond the medication-use phase and medication type. They identified best practices for using internal medication-related safety data. These lessons can be applied to the incorporation of AI as more tools and literature support become available.

NEJM CatalystVol. 7(12)
University of Southern California (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of California, Los Angeles (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), Keck Hospital of USC (US), Los Angeles Medical Center (US), Dana-Farber Cancer Institute (US)
Good health and well-being
Patient Safety and Medication Errors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon